Valuation: TransMedics Group, Inc.

Market Cap 2.89B 2.55B 2.41B 2.18B 4.11B 277B 4.16B 28.89B 11.12B 142B 10.87B 10.63B 455B P/E 2026 *
61x
P/E 2027 * 38.3x
Enterprise Value 2.85B 2.51B 2.38B 2.15B 4.05B 274B 4.1B 28.48B 10.96B 140B 10.71B 10.48B 448B EV / Sales 2026 *
3.85x
EV / Sales 2027 * 3.14x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-0.74%
1 week-4.08%
1 month-1.67%
3 months+25.64%
6 months-16.05%
Current year-31.40%
1 week 81.55
Extreme 81.55
86.38
1 month 79.23
Extreme 79.23
90.67
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 46 2026-09-20
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 Buy

Director

1,336 0.0039%
8/17/26 Don

Chairman

-18,000 0.0528%
7/10/26 Free

Chief Financial Officer

43,399 0.1273%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-4.08%-25.62%+52.42% 2.92B
-0.67%+1.47%+39.18%+33.36% 251B
-1.84%-0.00%+11.75%-10.70% 159B
-1.35%+2.09%-9.08%+39.12% 146B
-0.52%-2.17%-55.29%-17.33% 63.59B
-2.00%-0.58%+10.99%+24.60% 50.77B
-1.55%+4.23%+34.25%+54.10% 49.35B
-1.76%+2.07%-17.49%-20.90% 48.75B
+2.47%+5.43%-4.18%+40.30% 45.1B
-0.87%+4.47%+46.56%+60.24% 43.55B
Average -0.88%+1.41%+3.11%+25.52% 85.99B
Weighted average by Cap. -1.03%+1.92%+11.67%+21.83%

Financials

2026 *2027 *
Net sales 742M 653M 619M 559M 1.05B 71.12B 1.07B 7.4B 2.85B 36.36B 2.79B 2.72B 117B 875M 770M 730M 659M 1.24B 83.87B 1.26B 8.73B 3.36B 42.88B 3.28B 3.21B 137B
Net income 50.86M 44.79M 42.43M 38.31M 72.2M 4.88B 73.13M 508M 195M 2.49B 191M 187M 7.99B 88.06M 77.54M 73.47M 66.33M 125M 8.44B 127M 879M 338M 4.32B 331M 323M 13.84B
Net Debt -40.26M -35.45M -33.59M -30.32M -57.15M -3.86B -57.89M -402M -155M -1.97B -151M -148M -6.33B -146M -128M -122M -110M -207M -13.97B -209M -1.45B -560M -7.14B -547M -535M -22.89B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-09-30 US$83.45 -0.74% 566,623
26-09-29 US$84.07 +1.62% 440,203
26-09-28 US$82.73 -3.00% 422,561
26-09-25 US$85.29 +1.66% 696,739
26-09-24 US$83.90 -3.56% 623,710
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
83.45USD
Average target price
97.30USD
Spread / Average Target
+16.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock